ATE216253T1 - Verfahren zur erhöhung der darmabsorption - Google Patents

Verfahren zur erhöhung der darmabsorption

Info

Publication number: ATE216253T1
Authority: AT; Austria
Prior art keywords: intestinal absorption; increase intestinal; enhancing; mammal; production
Prior art date: 1991-10-07

Application number

AT92921577T

Other languages

English (en)

Inventor

Douglas Wilmore

Original Assignee

Brigham & Womens Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-07

Filing date

1992-10-07

Publication date

2002-05-15

1992-10-07 Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital

2002-05-15 Application granted granted Critical

2002-05-15 Publication of ATE216253T1 publication Critical patent/ATE216253T1/de

Links

238000000034 method Methods 0.000 title abstract 2
230000031891 intestinal absorption Effects 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 4
102000018997 Growth Hormone Human genes 0.000 abstract 3
108010051696 Growth Hormone Proteins 0.000 abstract 3
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 abstract 3
102100037852 Insulin-like growth factor I Human genes 0.000 abstract 3
230000002708 enhancing effect Effects 0.000 abstract 3
239000000122 growth hormone Substances 0.000 abstract 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 2
238000010521 absorption reaction Methods 0.000 abstract 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Zoology (AREA)
Immunology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Compounds Of Unknown Constitution (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)

AT92921577T 1991-10-07 1992-10-07 Verfahren zur erhöhung der darmabsorption ATE216253T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US77141591A	1991-10-07	1991-10-07
PCT/US1992/008445 WO1993006839A1 (en)	1991-10-07	1992-10-07	Method for enhancing gut absorption

Publications (1)

Publication Number	Publication Date
ATE216253T1 true ATE216253T1 (de)	2002-05-15

Family

ID=25091736

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92921577T ATE216253T1 (de)	1991-10-07	1992-10-07	Verfahren zur erhöhung der darmabsorption

Country Status (11)

Country	Link
US (1)	US5288703A (de)
EP (1)	EP0607278B1 (de)
JP (1)	JP3614427B2 (de)
AT (1)	ATE216253T1 (de)
AU (1)	AU661242B2 (de)
CA (1)	CA2120626C (de)
DE (1)	DE69232561T2 (de)
DK (1)	DK0607278T3 (de)
ES (1)	ES2174838T3 (de)
IL (1)	IL103383A0 (de)
WO (1)	WO1993006839A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH10509417A (ja) *	1994-09-21	1998-09-14	ファルマキアアンドウプジョンアーベー	妊娠した哺乳動物の高血圧を処置する方法
GB9609993D0 (en) *	1996-05-14	1996-07-17	Norbrook Lab Ltd	Oral rehydration product
GB2329336B (en) *	1996-05-14	1999-11-10	Norbrook Lab Ltd	Oral rehydration product comprising glutamine
US5952301A (en) *	1996-12-10	1999-09-14	1149336 Ontario Inc.	Compositions and methods for enhancing intestinal function
US5981590A (en) *	1997-03-17	1999-11-09	Probiotix, Inc.	Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
US6051557A (en) *	1997-05-16	2000-04-18	1149336 Ontario Inc.	Methods of enhancing functioning of the upper gastrointestinal tract
JP2004536834A (ja) *	2001-07-06	2004-12-09	オークランドユニサーヴィシズリミテッド	高血圧症治療
US20030099722A1 (en) *	2001-10-09	2003-05-29	Baxter Jeffrey H.	Methods and compositions for providing glutamine
DE60319822T2 (de)	2002-06-19	2009-06-04	Actogenix Nv	Verfahren und mittel zur erhöhung der darmabsorption
US7323206B1 (en)	2003-03-04	2008-01-29	B. Braun Medical Inc.	Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
ES2389805T3 (es) *	2003-09-12	2012-10-31	University Of Colorado	Glutamina para su uso en el tratamiento de una lesión
PL370937A1 (pl) *	2004-10-29	2006-05-02	Sgp & Sons Ab	Preparat żywieniowy i/lub farmaceutyczny do stosowania w profilaktyce i leczeniu niedoborów wchłaniania mikroelementów z przewodu pokarmowego oraz zastosowanie preparatu farmaceutycznego jako czynnika stymulującego wchłanianie mikroelementów z przewodu pokarmowego do krwi
DK2119450T3 (da)	2005-11-29	2013-05-06	Actogenix Nv	Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
BRPI0807857A2 (pt)	2007-01-25	2014-05-27	Actogenix Nv	Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
WO2018079573A1 (ja) *	2016-10-26	2018-05-03	味の素株式会社	消化管における吸収低下の改善用組成物、および消化管における吸収の促進用組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU598205B2 (en) *	1985-08-22	1990-06-21	Gropep Pty Ltd	Peptide analogues of mammalian insulin-like growth factor-1
US4857555A (en) *	1985-09-12	1989-08-15	Brigham & Women's Hospital	Method of treating catabolic dysfunction
US4863901A (en) *	1986-01-09	1989-09-05	Brigham & Women's Hospital	Use of growth hormone for nitrogen retention under hypocaloric conditions
US4876242A (en) *	1987-09-21	1989-10-24	Merck & Co., Inc.	Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast
EP0346429B1 (de) *	1987-12-24	1994-12-28	Gropep Pty. Ltd.	Peptid-analoge vom insulinähnlichen wachstums-faktor 1 (igf-1) oder faktor 2 (igf-2)
US5122512A (en) *	1988-09-12	1992-06-16	Pitman-Moore, Inc.	Swine growth promoting composition
SE9002732D0 (sv) *	1990-08-24	1990-08-24	Kabivitrum Ab	Product containing growth factor

1992
- 1992-10-07 EP EP92921577A patent/EP0607278B1/de not_active Expired - Lifetime
- 1992-10-07 ES ES92921577T patent/ES2174838T3/es not_active Expired - Lifetime
- 1992-10-07 JP JP50710393A patent/JP3614427B2/ja not_active Expired - Lifetime
- 1992-10-07 US US07/957,174 patent/US5288703A/en not_active Expired - Lifetime
- 1992-10-07 CA CA002120626A patent/CA2120626C/en not_active Expired - Lifetime
- 1992-10-07 DE DE69232561T patent/DE69232561T2/de not_active Expired - Lifetime
- 1992-10-07 DK DK92921577T patent/DK0607278T3/da active
- 1992-10-07 WO PCT/US1992/008445 patent/WO1993006839A1/en not_active Ceased
- 1992-10-07 AU AU27906/92A patent/AU661242B2/en not_active Expired
- 1992-10-07 AT AT92921577T patent/ATE216253T1/de active
- 1992-10-08 IL IL103383A patent/IL103383A0/xx unknown

Also Published As

Publication number	Publication date
AU661242B2 (en)	1995-07-13
AU2790692A (en)	1993-05-03
EP0607278B1 (de)	2002-04-17
ES2174838T3 (es)	2002-11-16
CA2120626C (en)	2009-10-06
IL103383A0 (en)	1993-03-15
JPH07501796A (ja)	1995-02-23
DE69232561D1 (de)	2002-05-23
DK0607278T3 (da)	2002-06-17
JP3614427B2 (ja)	2005-01-26
EP0607278A1 (de)	1994-07-27
EP0607278A4 (de)	1995-03-29
US5288703A (en)	1994-02-22
DE69232561T2 (de)	2002-11-28
WO1993006839A1 (en)	1993-04-15
CA2120626A1 (en)	1993-04-15

Similar Documents

Publication	Publication Date	Title
DE69232561D1 (de)	2002-05-23	Verfahren zur erhöhung der darmabsorption
DE3585867D1 (de)	1992-05-21	Analoge vom wachstumshormon befreiter faktor und dessen verfahren.
DE69219607D1 (de)	1997-06-12	Verfahren zur anregung der immunresponz
DK582188A (da)	1988-10-19	Stabile interferonkomplekser
FI911319A0 (fi)	1991-03-18	Polypeptidderivat.
DE69334035D1 (de)	2006-08-03	Verfahren zur vorbeugung von nmda-rezeptor vermittelten neuronalen schäden
SE9003665D0 (sv)	1990-11-16	Morphine prodrugs
ATE254095T1 (de)	2003-11-15	Selektive analoge der thyroidhormone
DE3889536D1 (de)	1994-06-16	Behandlung von krebs mit somatostatin und mit analogen davon.
EA200000748A1 (ru)	2000-12-25	Способ введения мономерных аналогов инсулина
DE69102401D1 (de)	1994-07-14	Verfahren zur Herstellung von kappa-Casein-Glycomakropeptid.
NZ208376A (en)	1988-07-28	Cyclic pentapeptide somatostatin antagonists and pharmaceutical compositions
EP0909562A4 (de)	1999-12-29	Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung
FI902433A7 (fi)	1990-11-20	Menetelmä jauhemaisen polydekstroosin valmistamiseksi, joka on olennaisesti vapaa hapoista ja sitä sisältäviä koostumuksia
DE69003906D1 (de)	1993-11-18	Triacetin enthaltende, langwirkende injizierbare Zusammensetzungen.
SE8202380L (sv)	1982-10-17	Analgetisk komposition
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
ATE121296T1 (de)	1995-05-15	Igf-i zur behandlung von nebeneffekten der steroidtherapie.
DE68921582D1 (de)	1995-04-27	Verfahren zur Herstellung von funktionellen Isothiocyanatometallkomplexen.
DE3880947D1 (de)	1993-06-17	Verfahren zur darstellung eines oxidischen supraleiters ohne ummantelung und ein nach diesem verfahren hergestellter oxidischer supraleiter.
ES2108122T3 (es)	1997-12-16	Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
DE69016375D1 (de)	1995-03-09	Orthodontisches Bracket und Verfahren und dessen Herstellung.
DE68905346D1 (de)	1993-04-22	3-(2-hydroperoxy-2-propyl)phenol und verfahren zur herstellung von resorcin mit diesem phenol.
EP0457848A4 (en)	1992-01-02	Treatment of pulmonary dysfunction and ventilator dependency with growth hormone
DE68914620D1 (de)	1994-05-19	Verfahren zur Herstellung der Restriktionsendonucklease PvuI.

Legal Events

Date	Code	Title	Description
2002-10-15	UEP	Publication of translation of european patent specification